Kiora Pharmaceuticals Inc [KPRX] stock is trading at $3.90, up 36.84%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KPRX shares have gain 31.76% over the last week, with a monthly amount glided 17.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kiora Pharmaceuticals Inc [KPRX] stock has fluctuated between $2.51 and $5.55 over the past year. Kiora Pharmaceuticals Inc [NASDAQ: KPRX] shares were valued at $3.90 at the most recent close of the market.
Analyzing the KPRX fundamentals
Kiora Pharmaceuticals Inc [NASDAQ:KPRX] reported sales of 0.02M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -799.19% with Operating Profit Margin at -546.1%, Pretax Profit Margin comes in at -493.17%, and Net Profit Margin reading is -602.57%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.43 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.41 points at the first support level, and at 2.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.28, and for the 2nd resistance point, it is at 4.67.
Ratios To Look Out For
For context, Kiora Pharmaceuticals Inc’s Current Ratio is 5.14. As well, the Quick Ratio is 5.14, while the Cash Ratio is 0.71. Considering the valuation of this stock, the price to sales ratio is 593.21, the price to book ratio is 0.49.
Transactions by insiders
Recent insider trading involved Stengone Carmine N., Director, that happened on Sep 11 ’24 when 1250.0 shares were purchased. Director, Shapiro Aron completed a deal on Sep 10 ’24 to buy 3000.0 shares. Meanwhile, Director Walters-Hoffert Lisa bought 1250.0 shares on Aug 19 ’24.
